Drug-controlled DROP-CARs enable reversible extracellular control of CAR T cell function via human-derived protein switches that modulate cell–cell interactions and support dual-antigen targeting as well as logic-gated signaling.
- Leo Scheller
- Greta Maria Paola Giordano Attianese
- Melita Irving